PPARD rs2016520: Understanding Your Genetic Variant
The rs2016520 variant is a single nucleotide polymorphism located within the PPARD gene. It has been studied for its potential associations with baseline cholesterol levels and other metabolic traits in various human populations.
What each genotype means
Baseline cholesterol profile
This genotype represents the common homozygous state for this variant. Research has associated this genetic position with baseline cholesterol levels, though the clinical significance of this specific genotype remains subject to ongoing study and individual variability. Please consult with a healthcare provider or lipid specialist to interpret your cholesterol levels in the context of your overall health and lifestyle.
This is a common genotype found in many populations, with the A allele being the major allele in most studied groups.
Baseline cholesterol profile
This heterozygous genotype is frequently observed in population studies investigating the PPARA gene. While some research suggests an association between this variant and variations in cholesterol levels, the effect size is generally considered modest and influenced by other genetic and environmental factors. Discuss your lipid panel results with your clinician to determine if any dietary or lifestyle adjustments are appropriate for you.
This genotype is carried by a significant portion of the population, consistent with the reported minor allele frequency of approximately 23%.
Baseline cholesterol profile
This genotype represents the homozygous state for the minor allele at this location. Studies have explored its association with lipid metabolism and cholesterol levels, but results are not definitive and may vary based on ancestry and dietary fat intake. As with any genetic marker related to metabolism, it should not be used in isolation to predict health outcomes; please review your cardiovascular health markers with a medical professional.
This is the least common of the three genotypes, occurring in roughly 1 in 20 to 1 in 10 individuals depending on ancestral background.
What is rs2016520?
A single nucleotide polymorphism, or SNP, is a variation at a single position in a DNA sequence among individuals. The variant rs2016520 is located on chromosome 6. In genetic databases, this SNP is associated with the PPARD gene, which encodes the peroxisome proliferator-activated receptor delta protein. This protein is a member of the nuclear receptor family, which acts as a transcription factor to regulate the expression of various genes. Because SNPs like rs2016520 represent common variations in the human genome, researchers study them to determine if they correlate with specific physical traits or health outcomes. It is important to note that the presence of a specific genotype at this location does not determine a health outcome on its own, but rather serves as a data point in the broader study of human genetic diversity and metabolic function.
The Role of the PPARD Gene
The PPARD gene provides instructions for making the PPAR-delta protein. This protein plays a significant role in regulating lipid and glucose metabolism. By binding to specific regions of DNA, PPAR-delta helps control the activity of genes involved in how the body processes fats and energy. Because of its central role in metabolic pathways, variations in the PPARD gene are of interest to scientists investigating how genetic differences might influence an individual's response to dietary intake or their baseline metabolic profile. Research into this gene often focuses on its influence on cholesterol metabolism and its potential interaction with environmental factors, such as physical activity or diet. Understanding the function of this gene is a key part of ongoing efforts to map how complex biological systems, like lipid regulation, are influenced by the underlying genetic code.
Research Associations and Evidence
Scientific research has explored the association between rs2016520 and various metabolic traits. Some studies have observed correlations between this variant and baseline cholesterol levels in large cohorts. Additionally, research has investigated whether variations in this gene might influence other traits, such as height or the risk of specific conditions like biliary stones, though these findings are often specific to certain populations or study designs. The evidence strength for these associations is generally considered moderate, meaning that while statistical signals have been detected, they do not imply a direct cause-and-effect relationship. Genetic associations are complex and often influenced by a combination of multiple genes, lifestyle factors, and environmental conditions. Consequently, findings from one study may not always be replicated in different populations, highlighting the need for cautious interpretation of genetic data in the context of personal health.
Interpreting Your Genetic Information
When reviewing information about genetic variants like rs2016520, it is essential to understand that this data is for educational purposes only. Genetic markers are not diagnostic tools and cannot predict individual health outcomes with certainty. If you are concerned about your cholesterol levels, metabolic health, or how your diet affects your body, the most appropriate course of action is to consult with a qualified healthcare provider or a registered dietitian. They can evaluate your clinical history, blood work, and lifestyle to provide personalized guidance. You should never use genetic information to make changes to your medical treatment or medication regimen without first discussing it with your clinician or pharmacist. Genetic research provides valuable insights into human biology, but it is only one piece of a much larger puzzle that includes your environment, habits, and overall medical history.
How common is this variant?
The rs2016520 variant is common across many populations, with a global minor allele frequency reported at approximately 23%.
Frequently asked questions
Can I use this SNP to predict my cholesterol levels?
No, this SNP cannot be used to predict your cholesterol levels. Cholesterol is a complex trait influenced by many genes, diet, exercise, and other environmental factors, and a single genetic variant has only a very small, if any, impact.
Is rs2016520 a diagnostic test for metabolic disease?
No, rs2016520 is not a diagnostic test. Genetic variants are used in research to understand biological pathways, but they are not used in clinical settings to diagnose metabolic conditions.
Should I change my diet based on my genotype for this SNP?
You should not change your diet based on this SNP. Always consult with a doctor or a registered dietitian before making significant changes to your diet, especially if you are managing a health condition.
Where can I find more information about my specific genetic results?
If you have received genetic testing results, you should discuss them with a genetic counselor or your primary care physician. They can help you interpret the information in the context of your overall health.
Sources & further reading
Educational information only, last refreshed 10/9/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2016520?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in PPARA
The PPARA Leu162Val missense substitution modulates fasting triglyceride levels and individual lipid responses to dietary polyunsaturated fatty acid (PUFA) intake.
Intron variant in PPARA associated with lipid substrate utilization and submaximal aerobic exercise capacity.
The Leu162Val variant in PPARA modulates lipid response and triglyceride clearance in response to dietary PUFA intake.
The PPARA Leu162Val polymorphism modulates fasting triglyceride and cholesterol responses to dietary polyunsaturated fatty acid (PUFA) intake.
Intronic regulatory polymorphism in PPARA associated with lipid metabolism and cardiovascular fitness profiles.
This SNP is associated with the capacity to improve VO2max in response to endurance training and metabolic efficiency.